The
The Fraunhofer ITMP is a leading research institute focused on the development of innovative methods for early detection, diagnosis, and therapy of diseases caused by impaired immune system functions. With locations in Frankfurt am Main, Hamburg, Göttingen, Berlin, and Penzberg/Munich, the institute works closely with universities and industry to translate scientific findings into practical applications.
The Fraunhofer ITMP sees itself as a bridge builder between science and industry, aiming to develop innovative solutions for inadequately treatable diseases. It places great importance on interdisciplinary collaboration and exchange with national and international partners.
Although specific sustainability goals are not explicitly mentioned, the institute focuses on developing sustainable medical solutions by integrating patient perspectives and promoting personalized medicine. The involvement of patients in research projects, such as in the IMPACT initiative, demonstrates the focus on patient-oriented research.
The Fraunhofer ITMP is involved in various innovative projects, including the development of synthetic data for personalized medicine as part of the Innovative Health Initiative (IHI) and the organization of symposia to promote new therapeutic approaches. Additionally, an Early Clinical Trial Unit has been established in Göttingen to support early clinical studies.
